ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,611, issued on July 1, was assigned to BroadenBio Co. Ltd. (Beijing).

"Bridged cycloformylpyridine derivatives and uses thereof" was invented by Qi Wang (Beijing), Gongping Duan (Beijing), Wei Hua (Beijing) and Xingmin Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a compound of formula (I), or a pharmaceutically acceptable salt, solvate, active metabolite, polymorph, isotopic label, isomer or prodrug thereof, and a use thereof. The above-mentioned compound has a very strong inhibitory effect on the FGFR4 kinase activity and the proliferative activity of Hep 3B cells with high FGFR4 expression."

The patent was filed on Oc...